Heart surgery patients get thyroid boost to cut complications
NCT ID NCT07380854
Summary
This study is testing whether giving a common thyroid medication (levothyroxine) to patients with a mild thyroid condition can reduce serious heart complications after bypass surgery. About 338 adults scheduled for bypass surgery will be randomly assigned to either receive the thyroid medication or not, starting the day before their operation. Researchers will track participants for up to five years to see if the medication helps prevent heart attacks, strokes, or other major heart-related events.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBCLINICAL HYPOTHYROIDISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Internal Medicine, Seoul National University Bundang Hospital
RECRUITINGSeongnam-si, 13620, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.